Background {#Sec1}
==========

*Ophiopogon japonicus* (L.f) Ker-Gawl (Convallariaceae) occurs widely in Vietnam and it has been used in traditional medicine to treat cough, fever, epistaxis, inflammation, respiratory disease, constipation, and gastrointestinal disorders \[[@CR1]\]. Steroidal saponins are among the main characteristic components of *O*. *japonicus* and have anticancer, anti-inflammatory, antioxidative, and neuritogenic effects \[[@CR2]--[@CR4]\]. Homoisoflavonoids are also characteristic of *O*. *japonicus* and possess anti-inflammatory, antioxidative, and cytotoxic activities \[[@CR4]--[@CR8]\]. *O*. *japonicus* is also rich in polysaccharides that have antidiabetic, antioxidative, anti-inflammatory, and immunomodulatory properties \[[@CR4], [@CR7]\]. In addition, phenolic acids, sesquiterpenes, fatty acids, and lignans have been identified from *O*. *japonicus* \[[@CR4], [@CR9], [@CR10]\].

Nitric oxide (NO) is produced by inducible nitric oxide synthase (iNOS) in macrophages, hepatocytes, and renal cells. When produced in excess, NO directly damages normal tissues and triggers inflammation. Therefore, inhibitors of NO production have potential therapeutic value as anti-inflammatory agents \[[@CR11]\]. In our search for anti-inflammatory compounds from natural sources, a methanol (MeOH) extract of the tubers of *O*. *japonicus* was found to strongly inhibit NO production. Phytochemical fractionation of the CHCl~3~-soluble fraction of the MeOH extract led to the isolation of five 2-benzyl benzofurans, including three new (**1**--**3**) and two known (**4**, **5**) compounds (Fig. [1](#Fig1){ref-type="fig"}). Compound **1** strongly inhibited NO production in lipopolysaccharide (LPS)-induced RAW264.7 cells.Fig. 1Structure of compounds **1**--**5** isolated from *O. japonicus* tubers

Results and discussion {#Sec2}
======================

Compound **1** was obtained as a brown solid. Its molecular formula was determined to be C~18~H~20~O~3~ from high-resolution electrospray ionisation mass spectrometry (HRESIMS) (*m*/*z* 283.1365 \[M − H\]^−^). Its ^1^H NMR spectrum showed the characteristic resonance of an AA′BB′ aromatic ring \[δ~H~ 7.19 (2H, d, *J* = 8.5 Hz, H-2′, 6′), and 6.86 (2H, d, *J* = 8.5 Hz, H-3′, 5′)\], one aromatic singlet \[δ~H~ 6.67 (1H, s, H-4)\], one oxygenated methine proton \[δ~H~ 4.86 (partially overlapped with HDO signal, H-2)\], one methoxyl group \[δ~H~ 3.78 (3H, s, 4′-OMe)\], two methylene groups \[δ~H~ 3.07 (1H, dd, *J* = 15.0, 8.5 Hz, Ha-3), 2.82 (1H, dd, *J* = 15.0, 7.5 Hz, Hb-3), 3.02 (1H, dd, *J* = 14.0, 7.0 Hz, Ha-7′), 2.84 (1H, dd, *J* = 14.0, 6.5 Hz, Ha-7′)\] and two aromatic methyl groups \[δ~H~ 2.12 (3H, s, Me-5) and 2.05 (3H, s, Me-7)\] (Table [1](#Tab1){ref-type="table"}). The ^13^C NMR and DEPT spectra revealed the presence of two methyl carbons at δ~C~ 9.2 (7-Me) and 16.5 (5-Me), two methylene carbons at δ~C~ 35.9 (C-3) and 42.0 (C-7′), one methoxy carbon at δ~C~ 55.7 (4′-OMe), one oxygenated methine carbon at δ~C~ 85.1 (C-2), five methine carbons at δ~C~ 123.9 (C-4), 131.4 (C-2′, 6′), and 114.7 (C-3′, 5′), and seven quaternary carbons at δ~C~ 153.8 (C-6, observed from HMBC spectrum), 158.1 (C-7a), and 159.8 (C-4′), 118.0 (C-3a), 117.3 (C-5), 108.1 (C-7), and 131.2 (C-1′) (Table [2](#Tab2){ref-type="table"}). These data suggested the 2-benzyl-2,3-dihydrobenzofuran skeleton of **1** \[[@CR12], [@CR13]\]. The HMBC correlations from aromatic singlet H-4 to C-3, C-3a, C-5, C6, C-7a, and from Me-5 to C-4, C-5, C-6, as well as from Me-7 to C-6, C-7, C-7a indicated the presence of a dihydrobenzofuran skeleton with a hydroxyl group located at C-6 and two methyl groups located at C-5 and C-7. The methoxyl group was placed on C-4′ based on the HMBC correlation of the proton of this group with C-4′ (Fig. [2](#Fig2){ref-type="fig"}). From these data, **1** was identified as 2-(4-methoxybenzyl)-5,7-dimethyl-6-hydroxyl-2,3-dihydrobenzofuran. The quantum chemical electronic circular dichroism (ECD) calculation method, based on time-dependent density functional theory (TDDFT), was used to determine of the absolute configuration at C-2 \[[@CR14]\]. The predicted ECD patterns for 2*R* were consistent with the experimentally measured ECD of **1** (Fig. [3](#Fig3){ref-type="fig"}). Thus, compound **1** was assigned as (2*R*)-(4-methoxybenzyl)-5,7-dimethyl-6-hydroxyl-2,3-dihydrobenzofuran.Table 1^1^H NMR data of compounds **1**--**5** (δ~H~ in ppm, *J* in Hz)Position**1** (CD~3~OD)**2** (CDCl~3~)**3** (CD~3~OD)**4** (CDCl~3~)**5** (CDCl~3~)24.86, partially overlapped5.05, m--5.00, m5.02, m33.07, dd (15.0, 8.5)\
2.82, dd (15.0, 7.5)3.15, dd (15.0, 8.5)\
2.94, dd (15.0, 8.5)6.16, s3.12, dd (15.0, 8.0)\
2.88, dd (15.0, 8.5)3.09, dd (15.0, 8.5)\
2.87, dd (15.0, 8.5)46.67, s6.87, s6.82, s6.74, d (8.0)6.58, d (8.0)5------6.38, d (8.0)6.36, d (8.0)7--6.39, s6.83, s----2′7.19, d (8.5)--7.10, d (8.5)7.18, d (8.5)7.17, d (8.5)3′6.86, d (8.5)6.48, d (2.5)6.74, d (8.5)6.85, d (8.5)6.85, d (8.5)5′6.86, d (8.5)6.43, dd (8.0, 2.5)6.74, d (8.5)6.85, d (8.5)6.85, d (8.5)6′7.19, d (8.5)6.98, d (8.0)7.10, d (8.5)7.18, d (8.5)7.17, d (8.5)7′3.02, dd (14.0, 7.0)\
2.84, dd (14.0, 6.5)3.07, dd (15.0, 3.5)\
3.01, dd (15.0, 7.0)3.91, s3.16, dd (14.0, 6.0)\
2.90, dd (14.0, 6.0)3.13, dd (14.0, 6.0)\
2.90, dd (14.0, 6.0)5-Me2.12, s2.10, s------7-Me2.05, s--------4′-OMe3.78, s3.75, s--3.79, s3.78, s6-OMe--3.76, s--3.82, s--7-OMe------3.93, s---OCH~2~O---------5.90, s Table 2^13^C NMR data of compounds **1**--**5**Position**1** (CD~3~OD)**2** (CDCl~3~)**3** (CD~3~OD)**4** (CDCl~3~)**5** (CDCl~3~)285.185.8158.385.386.2335.934.0103.534.334.53a118.0117.2122.0121.2122.94123.9126.2106.0118.3116.85117.3119.0143.1109.9104.36153.8157.8144.3152.1148.77108.193.698.6133.7130.07a158.1157.2150.7151.4141.91′131.2116.2130.1129.3129.12′131.4156.2130.8130.4130.33′114.7102.9116.2113.9113.94′159.8160.2157.0158.4158.35′114.8106.4116.2113.9113.96′131.4132.1130.8130.4130.37′42.036.934.840.940.75-Me16.515.8------7-Me9.2--------4′-OMe55.755.6--55.355.26-OMe--55.3--56.4--7-OMe------60.5---OCH~2~O---------100.2 Fig. 2Key HMBC correlations of **1**--**3** Fig. 3Experimental and calculated CD spectrum for compound **1**

Compound **2** was obtained as a brown solid. Analysis of the HRESIMS spectrum indicated that compound **2** has molecular formula C~18~H~20~O~4~ (*m*/*z* 301.1436 \[M + H\]^+^). The ^1^H NMR spectrum of **2** showed the presence of two aromatic singlets (δ~H~ 6.87 and 6.39), an aromatic ABX spin system \[δ~H~ 6.48 (1H, d, *J* = 2.5 Hz, H-3′), 6.43 (1H, dd, *J* = 8.0, 2.5 Hz, H-5′), and 6.98 (1H, d, *J* = 8.0 Hz, H-6′)\], one aromatic methyl (δ~H~ 2.10) and two methoxy groups (δ~H~ 3.75 and 3.76). The ^13^C NMR and DEPT spectra of **2** showed the characteristics of 2-benzyl-2,3-dihydrobenzofuran, which are similar to those of **1** with one oxygenated methine carbon at δ~C~ 85.8 (C-2) and two methylenes at 34.0 (C-3) and 36.9 (C-7) (Table [2](#Tab2){ref-type="table"}). The HMBC correlations confirmed the positions of the methyl and methoxy groups (Fig. [2](#Fig2){ref-type="fig"}). In a test of the optical rotation, this compound was optically inactive. Therefore, the structure of compound **2** was determined to be 2-(2-hydroxyl-4-methoxy-benzyl)-5-methyl-6-methoxyl-2,3-dihydrobenzofuran.

Compound **3** was obtained as a brown solid. Its HRESIMS revealed a molecular ion peak at *m*/*z* 255.0632 \[M − H\]^−^ corresponding to a molecular formula of C~15~H~12~O~4~. The ^1^H NMR spectrum showed signals due to an olefinic proton \[δ~H~ 6.16 (1H, s)\], two aromatic protons \[δ~H~ 6.82 (1H, s), and 6.83 (1H, s)\], a 1,4-disubstituted benzene ring with two apparent doublets \[δ~H~ 7.10 (2H, d, *J* = 8.5 Hz), 6.74 (2H, d, *J* = 8.5 Hz)\], and a methylene group \[δ~H~ 3.91 (2H, s)\]. The ^13^C NMR and DEPT experiments showed one methylene, seven methines, five oxygenated aromatic carbons, and two quaternary carbons. In the HMBC spectrum, the correlations between the olefinic proton (δ~H~ 6.16, H-3) and C-3a (δ~C~ 122.0), C-4 (δ~C~ 106.0), and C-7a (δ~C~ 150.7), H-4/C-3 (δ~C~ 103.5), C-3a, C-5 (δ~C~ 143.1), C-6 (δ~C~ 144.3), and C-7a, as well as H-7/C-3a, C-5, C-6, and C-7a indicated the presence of a benzofuran skeleton with two oxygen substituents on ring A (Fig. [2](#Fig2){ref-type="fig"}). Similarly, the correlations between the 1,4-disubstituted protons (δ~H~ 7.10, H-2′,6′) and the oxygenated aromatic carbon (δ~C~ 157.0) and the methylene carbon (δ~C~ 34.8) indicated the presence of a 4-hydroxybenzyl group. Moreover, the HMBC correlations of the methylene protons (δ~H~ 3.19, H-7′) with C-2, C-3, and C-4 suggested the location of the 4-hydroxy-benzyl group at C-2 (Additional file [1](#MOESM1){ref-type="media"}). This compound was also optically inactive. Therefore, the structure of **3** was assigned as 2-(4-hydroxy-benzyl)-5,6-dihydroxybenzofuran.

Compounds **4** and **5** were identified as 2-(4-methoxy-benzyl)-6,7-dimethoxyl-2,3-dihydrobenzofuran, and 2-(4-methoxy-benzyl)-6,7-methylenedioxy-2,3-dihydrobenzofuran, respectively \[[@CR12]\]. Both compounds were isolated for the first time from the nature. It is noted that the class of 2-benzyl-2,3-dihydrobenzofuran is uncommon and only a few compounds of this type have been isolated so far from natural source \[[@CR15]\].

The isolated compounds were tested for their ability to inhibit NO production in LPS-stimulated RAW264.7 cells. NO is an important signalling molecule in various physiological and pathophysiological responses, including the circulation, blood pressure, platelet function, and host defence. The overproduction of NO is also important in inflammation and related processes \[[@CR16]\]. High NO levels are used as a marker for the treatment of inflammatory disorders. According to its specific functions and characteristics, inhibition of NO production by immune cells, typically macrophages, is suggested as one strategy for the development of anti-inflammatory agents. Our test revealed that compounds **1** and **2** reduced NO levels in LPS-stimulated RAW264.7 cells. Compound **1** was the most active compound with an IC~50~ of 11.4 μM, while compound **2** had a moderate effect (IC~50~ = 29.1 μM). Compounds **3**--**5** were inactive up to the highest concentration tested (30 μM). The cell viability test showed that neither compound had significant toxicity at its effective dose for NO inhibition (data not shown). 2,3-Dihydrobenzofurans have been known as potent anti-inflammatory compounds. Closse et al. \[[@CR17]\] demonstrated that the synthetic analogues of 2,3-dihydrobenzofuran-2-one had powerful anti-inflammatory activity in vivo, and 5-chloro-6-cyclohexyl-2,3-dihydrobenzofuran-2-one was significantly more potent than the reference compound, diclofenac, in all testing models. More recently, a series of dihydrobenzofurans was isolated from the seeds of *Prunus tomentosa*, some of which strongly inhibited NO production in LPS-stimulated BV-2 cells \[[@CR18]\]. Consistently, our results suggest that *O*. *japonicus* is a potential natural source of anti-inflammatory dihydrobenzofurans.

Methods {#Sec3}
=======

General experimental procedures {#Sec4}
-------------------------------

Optical rotation values were recorded on a JASCO P-2000 digital polarimeter (JASCO, Tokyo, Japan). The IR spectra were obtained from a Tensor 37 FT-IR spectrometer (Bruker, Ettlingen, Germany). CD spectra were obtained with a JASCO J-1100 spectropolarimeter. NMR experiments were carried out on a Bruker AM500 FT-NMR spectrometer (Bruker, Rheinstetten, Germany) using residual solvent peak as a reference or tetramethylsilane (TMS) as internal standard. The HR-ESI-MS were recorded on a Waters Q-TOF micromass spectrometer Waters Q-TOF micromass spectrometer and an LTQ Orbitrap XL™ Mass spectrometer. Absorbance of bioassay solutions was read on an xMark microplate spectrophotometer.

Plant materials {#Sec5}
---------------

The tubers of *O. japonicus* were collected in Feb. 2014 at Me Linh, Hanoi and identified by Prof. Tran Huy Thai, Institute of Ecology and Biological Resources, Vietnam Academy of Science and Technology. The voucher specimens were deposited at the Department of Bioactive Products, Institute of Marine Biochemistry, Vietnam Academy of Science and Technology.

Extraction and isolation {#Sec6}
------------------------

The air-dried and powdered tubers of *O. japonicus* (2.4 kg) were extracted with methanol (4 L × 3 times) in a sonic bath for 30 min at 40 °C. The combined extracts were concentrated under a vacuum to obtain a crude residue (360 g), which was then resuspended in water (2 L), and extracted by chloroform (1 L × 3 times) to obtain chloroform (8 g) and water residues. The chloroform residue was chromatographed on a silica gel column eluted with a gradient of 1--100% ethyl acetate in hexane to afford nine fractions F1--F9. Fraction F1 was fractionated on a silica gel column eluted with hexane--ethyl acetate (20:1 v/v) to give nine subfractions F1.1--F1.9. Compound **5** (69.5 mg) was purified from F1.4 by using a reverse phase C~18~ column eluted with acetone--water (2:1 v/v). Compound **1** (70.0 mg) and **4** (18.2 mg) were isolated from F1.7 by using a reverse phase C~18~ column eluted with acetone--water (3:2 v/v). The F1.9 was chromatographed on a silica gel column (hexane--acetone 8:1, v/v) to afford **2** (20.8 mg). Compound **3** (20.0 mg) was obtained from F9 by repeated C~18~ column (methanol--water 1:1 v/v) and silica gel column (dichloromethane-acetone 6:1, v/v).

(2R)-(4-methoxybenzyl)-5,7-dimethyl-6-hydroxyl-2,3-dihydrobenzofuran (1) {#Sec7}
------------------------------------------------------------------------

Brown solid. \[α\]~D~^24^ = + 86.5 (*c* 0.05, MeOH). IR (KBr): 3446, 1615, 1513, 1472, 1247, 1097. CD (MeOH): 220 (+17.8), 288 (+3.2). ^1^H-(CD~3~OD, 500 MHz) and ^13^C-NMR (CD~3~OD, 125 MHz): see the Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. HR-ESI-MS (neg.): 283.1365 \[M − H\]^−^ (calc. for C~18~H~19~O~3~, 283.1334).

2-(2-Hydroxyl-4-methoxy-benzyl)-5-methyl-6-methoxyl-2,3-dihydrobenzofuran (2) {#Sec8}
-----------------------------------------------------------------------------

Brown solid. IR (KBr): 3440, 1610, 1482, 1245, 1120. ^1^H-(CDCl~3~, 500 MHz) and ^13^C-NMR (CDCl~3~, 125 MHz): see the Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. HR-ESI-MS (pos.): 301.1436 \[M + H\]^+^ (calc. for C~18~H~21~O~4~, 301.1440).

2-(4-Hydroxy-benzyl)-5,6-dihydroxybenzofuran (3) {#Sec9}
------------------------------------------------

Brown solid. IR (KBr): 3450, 1613, 1514, 1484, 1242, 1142. ^1^H-(CD~3~OD, 500 MHz) and ^13^C-NMR (CD~3~OD, 125 MHz): see the Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. HR-ESI-MS (neg.): 255.0632 \[M − H\]^−^ (calc. for C~15~H~11~O~4~, 255.0657).

Assay for inhibition of NO production {#Sec10}
-------------------------------------

The effects of compounds on the NO production in LPS-stimulated RAW264.7 cells were evaluated as previously described \[[@CR19]\]. The cells were seeded in 96-well plate at 2 × 10^5^ cells/well and incubated for 12 h. The plate were pretreated with compounds in various concentrations (from 1 to 30 µM) for 30 min and then incubated for another 24 h with or without 1 μg/ml LPS. 100 μl of the culture supernatant were transferred to other 96-well plate and 100 μl of Griess reagent were added. The absorbance of the reaction solution was read at 570 nm with a microplate reader (XMark microplate reader, Biorad, USA). The remaining cell solutions in cultured 96-well plate were used to evaluate cell viability by 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Cardamonin was used as a positive control (IC~50~ = 2.80 μM).

Conclusion {#Sec11}
==========

In summary, three 2-benzyl-2,3-dihydrobenzofurans and two 2-benzyl-benzofurans were isolated from the CHCl~3~-soluble fraction of the MeOH extract of *O*. *japonicus* tubers. Their structures were found to be (2*R*)-(4-methoxybenzyl)-5,7-dimethyl-6-hydroxyl-2,3-dihydrobenzofuran (**1**), 2-(2-hydroxyl-4-methoxy-benzyl)-5-methyl-6-methoxyl-2,3-dihydrobenzofuran (**2**), 2-(4-hydroxy-benzyl)-5,6-dihydroxybenzofuran (**3**), 2-(4-methoxy-benzyl)-6,7-dimethoxyl-2,3-dihydrobenzofuran (**4**), and 2-(4-methoxy-benzyl)-6,7-methylenedioxy-2,3-dihydrobenzofuran (**5**). Compounds **1** and **2** inhibited NO production in LPS-stimulated RAW264.7 cells.

Additional file {#Sec12}
===============

**Additional file 1.** NMR spectra of compounds **1**--**3**.

NHD and NTD designed research and wrote the paper; NDC, HMT and NVT performed research; NTH and DL analyzed CD data. All authors read and approved the final manuscript.

Acknowledgements {#FPar1}
================

This work is supported by the National Foundation for Science and Technology Development (NAFOSTED 104.01-2014.05). We thank the Institute of Chemistry (VAST) for the NMR experiments.

Competing interests {#FPar2}
===================

The authors declare that they have no competing interests.
